Switch to
View more

Beryl Drugs Ltd

BERLDRG
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4 cr, stock is ranked 3,887
High RiskStock is 3.93x as volatile as Nifty
8.080.40 (-4.72%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4 cr, stock is ranked 3,887
High RiskStock is 3.93x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-6.12
PB RatioPB Ratio
0.52
Dividend YieldDiv. Yield
Sector PESector PE
32.89
Sector PBSector PB
4.57
Sector Div YldSctr Div Yld
0.97%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Beryl Drugs is engaged in the manufacturing of allopathic pharmaceuticals preparations.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201920202021202213.2013.0514.7114.770.580.050.23-0.67
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Board Meeting 
Announced OnMay 16, 2022

BERYL DRUGS LTD. - 524606 - Update on board meeting | Download

BERYL DRUGS LTD. - 524606 - Update on board meeting | Download

Board Meeting 
Announced OnMay 16, 2022

BERYL DRUGS LTD. - 524606 - Board Meeting Intimation for Consider And Adopt The Audited Accounts For The Year Ended March 31, 2022 As Per Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, | Download

BERYL DRUGS LTD. - 524606 - Board Meeting Intimation for Consider And Adopt The Audited Accounts For The Year Ended March 31, 2022 As Per Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, | Download

See all events